WallStreetZenWallStreetZen

AnalystsCharles Duncan
Charles Duncan's Stock Forecasts

Analyst Ranking
Top 2%
#73 out of 4166 analysts
Average Return
+37.78%
Win Rate
41%27 out of 66
Risk vs Reward
Poor
Good

Charles Duncan's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Novavax IncNVAX
+2,273.26%$9.50$225.46
2020-03-17 -
2021-03-17
Strong Buy
Cassava Sciences IncSAVA
+390.45%$9.32$45.71
2020-10-23 -
2021-10-22
Strong Buy
Aimmune Therapeutics IncAIMT
+175.26%$12.53$34.49
2020-03-23 -
2020-10-12
Strong Buy
Novavax IncNVAX
+169.36%$64.75$174.41
2020-06-19 -
2021-06-18
Strong Buy
Biovie IncBIVI
+128.51%$2.21$5.05
2022-07-22 -
2023-01-27
Strong Buy

Charles Duncan's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Prothena Corp Public Ltd CoPRTA
2Strong Buy$98.00+71.57%Maintains
a month ago
Anavex Life Sciences CorpAVXL
2Hold$11.00+4.17%Downgrades
2 months ago
Fennec Pharmaceuticals IncFENC
2Strong Buy$12.00+26.85%Upgrades
2 months ago
Neurocrine Biosciences IncNBIX
1Strong Buy$132.00+21.94%Maintains
3 months ago
Cognition Therapeutics IncCGTX
1Strong Buy$12.00+494.06%Initiates Coverage On
4 months ago
Cerevel Therapeutics Holdings IncCERE
1Strong Buy$41.00+19.08%Initiates Coverage On
4 months ago
Vaxart IncVXRT
2Strong Buy$8.00+620.72%Maintains
5 months ago
Biovie IncBIVI
1Strong Buy$7.00+38.61%Initiates Coverage On
6 months ago
Axsome Therapeutics IncAXSM
4Strong Buy$64.00-8.92%Maintains
7 months ago
Acadia Pharmaceuticals IncACAD
6Strong Buy$26.00+40.01%Maintains
7 months ago
Novavax IncNVAX
6Strong Buy$168.00+1,388.04%Maintains
8 months ago
Stoke Therapeutics IncSTOK
1Strong Buy$38.00+294.60%Maintains
8 months ago
Harmony Biosciences Holdings IncHRMY
1Strong Buy$63.00+29.71%Initiates Coverage On
10 months ago
Aptinyx IncAPTX
1Strong Buy$5.00+1,090.48%Maintains
10 months ago
Oramed Pharmaceuticals IncORMP
1Strong Buy$20.00+930.93%Initiates Coverage On
a year ago
Vtv Therapeutics IncVTVT
2Strong Buy$5.00+405.05%Initiates Coverage On
a year ago
Bionomics LimitedBNOX
1Strong Buy$52.00N/AInitiates Coverage On
a year ago
Cardiol Therapeutics IncCRDL
1Strong Buy$8.00N/AInitiates Coverage On
a year ago
Lucid Diagnostics IncLUCD
1Strong Buy$21.00N/AInitiates Coverage On
a year ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
4Strong Buy$165.00N/AMaintains
a year ago
Cybin IncCYBN
1Strong Buy$9.00N/AInitiates Coverage On
a year ago
Atai Life Sciences NvATAI
1Strong Buy$45.00N/AInitiates Coverage On
2 years ago
Seelos Therapeutics IncSEEL
1Strong Buy$10.00N/AInitiates Coverage On
2 years ago
Clene IncCLNN
1Strong Buy$22.00N/AInitiates Coverage On
2 years ago
Ovid Therapeutics IncOVID
1Hold$4.00N/ADowngrades
2 years ago
Lumos Pharma IncLUMO
1Strong Buy$32.00N/AInitiates Coverage On
2 years ago
Cassava Sciences IncSAVA
1Strong Buy$24.00N/AInitiates Coverage On
2 years ago
Inovio Pharmaceuticals IncINO
5Hold$12.00N/ADowngrades
2 years ago
Prevail Therapeutics IncPRVL
1Strong Buy$26.00N/AInitiates Coverage On
2 years ago
Geron CorpGERN
1Strong Buy$4.00N/AMaintains
3 years ago
Halozyme Therapeutics IncHALO
2Strong Buy$39.00N/AReiterates
3 years ago
Cara Therapeutics IncCARA
1Strong Buy$34.00N/AReiterates
3 years ago
Cytokinetics IncCYTK
1Strong Buy$23.00N/AReiterates
3 years ago
Aimmune Therapeutics IncAIMT
2Strong Buy$32.00N/AMaintains
3 years ago
Reata Pharmaceuticals IncRETA
2Strong Buy$320.00N/AReiterates
3 years ago
Intra Cellular Therapies IncITCI
3Strong Buy$47.00N/AReiterates
3 years ago
Catalyst Pharmaceuticals IncCPRX
1Strong Buy$12.00N/AReiterates
3 years ago
Adamas Pharmaceuticals IncADMS
1Hold$7.00N/AReiterates
3 years ago
Corcept Therapeutics IncCORT
3Hold$14.00N/ADowngrades
4 years ago
Vanda Pharmaceuticals IncVNDA
1Hold$26.00N/AInitiates Coverage On
4 years ago
Acorda Therapeutics IncACOR
1Hold$32.00N/AInitiates Coverage On
4 years ago
Sangamo Therapeutics IncSGMO
1Strong BuyN/AN/AUpgrades
5 years ago
Altimmune IncALT
1Strong Buy$6.00N/AInitiates Coverage On
5 years ago
Zynerba Pharmaceuticals IncZYNE
1Strong BuyN/AN/AUpgrades
5 years ago
Pdl Biopharma IncPDLI
1Strong Buy$4.00N/AReinstates
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.